Fecal expression of human β-defensin-2 following birth

Neonatology

Volumn 98, Issue 4, 2010, Pages 365-369

  Campeotto, F ^a,b   Baldassarre, M ^c   Laforgia, N ^c   Viallon, V ^e   Kalach, N ^a   Amati, L ^f   Butel, M J ^b   Dupont, C ^a   Kapel, N ^b,d  

^a HÔPITAL SAINT VINCENT DE PAUL   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c UNIVERSITY OF BARI   (Italy)

^d Groupe Hospitalier Cochin Port Royal ^*  (Italy)

^e ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^f Hospital IRCCS de Bellis   (Italy)

Author keywords

Defensin 2; Feces; Necrotizing enterocolitis

Indexed keywords

BETA DEFENSIN 2;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FECES ANALYSIS; FEMALE; GESTATIONAL AGE; HUMAN; MALE; NECROTIZING ENTEROCOLITIS; NEWBORN; NEWBORN PERIOD; PREMATURITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECTUM HEMORRHAGE;

BETA-DEFENSINS; ENTEROCOLITIS, NECROTIZING; FECES; GASTROINTESTINAL HEMORRHAGE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; OCCULT BLOOD;

EID: 77958498267     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000315872     Document Type: Article

References (27)

1. Newburg DS, Walker WA: Protection of the neonate by the innate immune system of developing gut and of human milk. Pediatr Res 2007; 61:2-8.
2. Kai-Larsen Y, Bergsson G, Gudmundsson GH, Printz G, Jornvall H, Marchini G, Agerberth B: Antimicrobial components of the neonatal gut affected upon colonization. Pediatr Res 2007; 61: 530-536.
3. Selsted ME, Miller SI, Henschen AH, Ouellette AJ: Enteric defensins: antibiotic peptide components of intestinal host defense. J Cell Biol 1992; 118:929-936.
4. Zasloff M: Antibiotic peptides as mediators of innate immunity. Curr Opin Immunol 1992; 4:3-7.
5. Salzman NH, Hung K, Haribhai D, Chu H, Karlsson-Sjoberg J, Amir E, Teggatz P, Barman M, Hayward M, Eastwood D, Stoel M, Zhou Y, Sodergren E, Weinstock GM, Bevins CL, Williams CB, Bos NA: Enteric defensins are essential regulators of intestinal microbial ecology. Nat Immunol 2010; 11:76-83.
6. Wehkamp J, Schmid M, Stange EF: Defensins and other antimicrobial peptides in inflammatory bowel disease. Curr Opin Gastroenterol 2007; 23: 370-378.
7. Salzman NH, Underwood MA, Bevins CL: Paneth cells, defensins, and the commensal microbiota: a hypothesis on intimate interplay at the intestinal mucosa. Semin Immunol 2007; 19: 70-83.
8. Fellermann K, Stange DE, Schaeffeler E, Schmalzl H, Wehkamp J, Bevins CL, Reinisch W, Teml A, Schwab M, Lichter P, Radlwimmer B, Stange EF: A chromosome 8 genecluster polymorphism with low human fS-defensin-2 gene copy number predisposes to Crohn's disease of the colon. Am J Hum Genet 2006; 79: 439-448.
9. Wehkamp J, Schmid M, Fellermann K, Stange EF: Defensin deficiency, intestinal microbes, and the clinical phenotypes of Crohn's disease. J Leukoc Biol 2005; 77: 460-465.
10. Yoshio H, Lagercrantz H, Gudmundsson GH, Agerberth B: First line of defense in early human life. Semin Perinatol 2004; 28: 304-311.
11. Mallow EB, Harris A, Salzman N, Russell JP, DeBerardinis RJ, Ruchelli E, Bevins CL: Human enteric defensins. Gene structure and developmental expression. J Biol Chem 1996; 271:4038-4045.
12. Salzman NH, Polin RA, Harris MC, Ruchelli E, Hebra A, Zirin-Butler S, Jawad A, Martin Porter E, Bevins CL: Enteric defensin expression in necrotizing enterocolitis. Pediatr Res 1998; 44: 20-26.
13. Wehkamp J, Fellermann K, Herrlinger KR Baxmann S, Schmidt K, Schwind B, Duchrow M, Wohlschlager C, Feller AC, Stange EF: Human fidefensin-2 but not fidefensin-1 is expressed preferentially in colonic mucosa of inflammatory bowel disease. Eur J Gastroenterol Hepatol 2002; 14:745-752.
14. Langhorst J, Wieder A, Michalsen A, Musial F, Dobos GJ, Rueffer A: Activated innate immune system in irritable bowel syndrome? Gut 2007; 56: 1325-1326.
15. Langhorst J, Junge A, Rueffer A, Wehkamp J, Foell D, Michalsen A, Musial F, Dobos GJ: Elevated human fS-defensin-2 levels indicate an activation of the innate immune system in patients with irritable bowel syndrome. Am J Gastroenterol 2009; 104:404-410.
16. Kapel N, Benahmed N, Morali A, Svahn J, Canioni D, Goulet O, Ruemmele FM: Fecal fidefensin-2 in children with inflammatory bowel diseases. J Pediatr Gastroenterol Nutr 2009; 48:117-120.
17. Campeotto F, Baldassarre M, Butel MJ, Viallon V, Nganzali F, Soulaines P, Kalach N, Lapillonne A, Laforgia N, Moriette G, Dupont C, Kapel N: Fecal calprotectin: cutoff values for identifying intestinal distress in preterm infants. J Pediatr Gastroenterol Nutr 2009; 48:507-510.
18. Schaller-Bals S, Schulze A, Bals R: Increased levels of antimicrobial peptides in tracheal aspirates of newborn infants during infection. Am J Respir Crit Care Med 2002; 165: 992-995.
19. Mondel M, Schroeder BO, Zimmermann K, Huber H, Nuding S, Beisner J, Fellermann K, Stange EF, Wehkamp J: Probiotic E. coli treatment mediates antimicrobial human |3-defensin synthesis and fecal excretion in humans. Mucosal Immunol 2009; 2: 166-172.
20. Nissen AC, van Gils CE, Menheere PP, Van den Neucker AM, van der Hoeven MA, Forget PP: Fecal calprotectin in healthy term and preterm infants. J Pediatr Gastroenterol Nutr 2004; 38:107-108.
21. Campeotto F, Butel MJ, Kalach N, Derrieux S, Aubert-Jacquin C, Barbot L, Francoual C, Dupont C, Kapel N: High faecal calprotectin concentrations in newborn infants. Arch Dis Child Fetal Neonatal Ed 2004; 89:F353-F355.
22. Baldassarre ME, Altomare MA, Fanelli M, Carbone D, Di Bitonto G, Mautone A, Laforgia N: Does calprotectin represent a regulatory factor in host defense or a drug target in inflammatory disease? Endocr Metab Immune Disord Drug Targets 2007; 7:1-5.
23. Voss E, Wehkamp J, Wehkamp K, Stange EF, Schroder JM, Harder J: Nod2/card15 mediates induction of the antimicrobial peptide human P-defensin-2. J Biol Chem 2006; 281: 2005-2011.
24. Penders J, Thijs C, Vink C, Stelma FF, Snijders B, Kummeling I, van den Brandt PA, Stobberingh EE: Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics 2006; 118: 511-521.
25. Yang D, Chertov O, Bykovskaia SN, Chen Q, Buffo MJ, Shogan J, Anderson M, Schroder JM, Wang JM, Howard OM, Oppenheim JJ: Betadefensins: linking innate and adaptive immunity through dendritic and T-cell CCR6. Science 1999; 286:525-528.
26. Campeotto F, Kalach N, Lapillonne A, Butel MJ, Dupont C, Kapel N: Time course of faecal calprotectin in preterm newborns during the first month of life. Acta Paediatr 2007; 96: 1531-1533.
27. Savino F, Castagno E, Calabrese R, Viola S, Oggero R, Miniero R: High faecal calprotectin levels in healthy, exclusively breastfed infants. Neonatology 2009; 97:299-304.